CHICAGO (PRWEB)
January 26, 2021

Ziegler, a specialty investment bank, is pleased to announce it served as the exclusive financial advisor to Bluegrass Orthopaedics on its partnership with Trivest Partners, L.P, together forming a new national Orthopedic management services organization (“MSO”).

Bluegrass Orthopaedics (“BGO”) is an orthopedic surgery group located in Lexington, KY that specializes in orthopedic surgery, imaging, and rehabilitation. The practice is comprised of 14 Board Certified and Fellowship Trained specialized physicians who offer sports medicine, total joint care, industrial medicine, and foot, ankle, hand care, and physical therapy from eight locations. Trivest also invested alongside the BGO physicians in Bluegrass Specialty Surgery Center (“BSSC”), a leading orthopedic ambulatory surgery center in Kentucky. Last year, BGO treated over 16,000 patients and performed more than 2,700 outpatient surgeries.

Bluegrass Orthopaedics will serve as the foundational group for Trivest’s new national platform in the orthopedics market. As part of the growth strategy, BGO and Trivest will focus on expanding the Company’s geographic presence through targeted add-on acquisitions, proactively recruiting new top-tier physicians to the practice, further developing ancillary service lines and revenue cycle management (RCM) solutions, and leading technologies to support best-in-class surgical performance.

“Andy Colbert and the Ziegler team made this deal possible. Their knowledge and expertise in the healthcare sector proved instrumental in leading successful negotiations while addressing the most important issues for our practice. Thanks to their involvement, we are off to an exciting and collaborative relationship with our new partner, Trivest. We believe that the Ziegler team is a true value-add to any group considering a strategic investment opportunity” said Dr. Greg D’Angelo, M.D., Senior Partner and President of Bluegrass Orthopaedics.

“We greatly enjoyed guiding BGO through the transaction with Trivest and are excited for them to be the foundational platform in a national Orthopedic growth strategy.” said Andrew Colbert, Senior Managing Director in Ziegler’s Corporate Finance practice and lead banker on this transaction.

Waller Lansden Dortch & Davis LLP provided legal counsel to Bluegrass Orthopaedics in connection with the transaction.

Ziegler’s Corporate Finance team is focused on delivering best-in-class advisory and financing solutions for companies and organizations across the healthcare industry. In our core practice areas of healthcare services, information technology, hospitals and senior living, Ziegler is one of the most active M&A firms offering innovative sell-side, buy-side, recapitalization/restructuring, equity private placement and strategic partnering services.

Andrew Colbert is a Senior Managing Director and founding member of Ziegler’s Healthcare Investment Banking Practice. Mr. Colbert specializes in advising physician groups on strategic and financing alternatives including merger and acquisitions, capital raising transactions and partnership development

For more information about Ziegler, please visit us at http://www.ziegler.com.

About Ziegler:

Ziegler is a privately held, national boutique investment bank, capital markets and proprietary investments firm. It has a unique focus on healthcare, senior living and education sectors, as well as general municipal and structured finance. Headquartered in Chicago with regional and branch offices throughout the U.S., Ziegler provides its clients with capital raising, strategic advisory services, fixed income sales, underwriting and trading as well as Ziegler Credit, Surveillance and Analytics. To learn more, visit http://www.ziegler.com.

Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client’s experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.

# # #

Share article on social media or email: